Product image of Glucos Viaflo Baxter (Glucose) supplied by GNH India

Glucos Viaflo Baxter

Active Ingredient:
Glucose
Origin:
EU

Glucos Viaflo Baxter (Glucose)

Glucos Viaflo Baxter is an intravenous solution whose active ingredient is glucose. It is supplied as a sterile liquid for infusion, intended for use in clinical settings within the European Union. The product provides a source of carbohydrate that can be administered directly into the bloodstream to support patients who require rapid glucose supplementation.

Manufacturer / TM Owner

Baxter Oy

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glucos Viaflo Baxter is used in medical practice to address short‑term needs for carbohydrate replacement. It may be employed in the following situations:

  • Management of hypoglycemia when oral intake is not possible.
  • Provision of energy during peri‑operative fasting.
  • Support for patients receiving parenteral nutrition.
  • Treatment of electrolyte imbalances associated with low blood glucose.
  • Stabilisation of blood glucose levels in critically ill patients.
  • Adjunct therapy during fluid resuscitation when glucose is indicated.

Side Effects

Glucos Viaflo Baxter may cause a range of reactions, most of which are mild and transient. Serious adverse events are uncommon but should be monitored.

Common

  • Mild hyperglycemia.
  • Local irritation at the infusion site.
  • Nausea or vomiting.
  • Headache.
  • Transient increase in serum osmolality.

Serious

  • Severe hyperglycemia leading to osmotic diuresis.
  • Allergic reaction or anaphylaxis.
  • Electrolyte disturbances (e.g., hypernatremia).
  • Fluid overload in patients with cardiac or renal impairment.

Precautions & Warnings

When using Glucos Viaflo Baxter, clinicians should consider several safety measures to minimise risk. Important precautions include:

  • Assess baseline blood glucose and monitor levels frequently during infusion.
  • Adjust dosage in patients with diabetes or impaired glucose tolerance.
  • Use caution in individuals with renal or cardiac failure due to risk of fluid overload.
  • Verify compatibility with other intravenous solutions before co‑administration.
  • Ensure proper aseptic technique to prevent infection.
  • Review patient history for known hypersensitivity to glucose solutions.
  • Document infusion rate and total volume administered.

Avoid Interactions

Glucos Viaflo Baxter can interact with other medications or solutions, influencing its safety and effectiveness. Interaction considerations are:

Avoid

  • Co‑administration with high‑dose insulin without close glucose monitoring.
  • Simultaneous infusion of hypertonic saline solutions that may exacerbate hypernatremia.

Use with caution

  • Concurrent use of diuretics that affect fluid balance.
  • Medications that alter glucose metabolism, such as glucocorticoids.
  • Electrolyte‑containing IV fluids that may affect serum osmolality.
  • Drugs that cause hypoglycemia, requiring careful glucose level checks.
  • Parenteral nutrition formulations that already contain glucose.

Frequently Asked Questions

Glucos Viaflo Baxter is designed to provide rapid intravenous glucose supplementation for patients who cannot receive oral carbohydrates.

It is commonly used for treating hypoglycemia, supporting peri‑operative patients, supplementing parenteral nutrition, and stabilising blood glucose in critically ill individuals.

Blood glucose should be measured before starting the infusion and then checked regularly, typically every 30‑60 minutes, depending on the patient’s condition.

Yes, but dosing must be individualized and glucose levels closely monitored to avoid hyperglycemia.

Common side effects include mild hyperglycemia, local infusion site irritation, nausea, headache, and transient increases in serum osmolality.

Serious reactions such as severe hyperglycemia, anaphylaxis, electrolyte disturbances, or fluid overload should be addressed promptly.

Contraindications include known hypersensitivity to glucose solutions and conditions where rapid glucose administration could be harmful, such as uncontrolled diabetes.

These patients require careful monitoring of fluid balance and may need reduced infusion rates to prevent overload.

Store the solution at controlled room temperature, protected from light, and discard any product that appears discolored or cloudy.

Compatibility should be verified before mixing; avoid co‑infusion with hypertonic saline or other solutions that could alter electrolyte balance.

The infusion rate should be determined by the prescribing clinician based on the patient’s glucose requirements and clinical status.

The regulatory status varies by region; in the EU it is typically supplied under prescription or hospital pharmacy control.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.